ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977